Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Synergistic antitumor activity between HER2 antibody-drug conjugate and chemotherapy for treating advanced colorectal cancer ; volume:15 ; number:3 ; day:5 ; month:3 ; year:2024 ; pages:1-13 ; date:3.2024
Cell death & disease ; 15, Heft 3 (5.3.2024), 1-13, 3.2024
- Urheber
-
Liu, Hongfu
Zhou, Dongdong
Liu, Dongqin
Xu, Xi
Zhang, Kai
Hu, Ruxia
Xiong, Peng
Wang, Changxin
Zeng, Xiangfu
Wang, Liefeng
Zhang, Shuyong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41419-024-06572-2
- URN
-
urn:nbn:de:101:1-2405101046357.031080964616
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Hongfu
- Zhou, Dongdong
- Liu, Dongqin
- Xu, Xi
- Zhang, Kai
- Hu, Ruxia
- Xiong, Peng
- Wang, Changxin
- Zeng, Xiangfu
- Wang, Liefeng
- Zhang, Shuyong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Molecular beam epitaxy growth and structural property of self-assembled InAs quantum dots on GaAs
Molecular beam epitaxy growth and structural property of self-assembled InAs quantum dots on GaAs
New conjugated polymers based on benzodifuranone and diketopyrrolopyrrole
Moist‐Defined Polymers with Tunable Multisteady Mechano‐Responsiveness Enabled by Imine‐Coordinated Boroxine
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
Pickering emulsions stabilized by polysaccharides-based micro/nanoparticeles
Causal impacts of smoking on pain conditions and the mediating pathways: a mendelian randomization study
Two-stage improved Grey Wolf optimization algorithm for feature selection on high-dimensional classification
First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors
The First FDA-Approved Antibody-Drug Conjugate
Combined therapy of dabrafenib and an anti-HER2 antibody–drug conjugate for advanced BRAF-mutant melanoma
Bone cement distribution may significantly affect the efficacy of percutaneous vertebroplasty in treating symptomatic Schmorl’s nodes
Molecular beam epitaxy growth and structural property of self-assembled InAs quantum dots on GaAs
Molecular beam epitaxy growth and structural property of self-assembled InAs quantum dots on GaAs
New conjugated polymers based on benzodifuranone and diketopyrrolopyrrole
Moist‐Defined Polymers with Tunable Multisteady Mechano‐Responsiveness Enabled by Imine‐Coordinated Boroxine
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
Pickering emulsions stabilized by polysaccharides-based micro/nanoparticeles
Causal impacts of smoking on pain conditions and the mediating pathways: a mendelian randomization study
Two-stage improved Grey Wolf optimization algorithm for feature selection on high-dimensional classification
First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors
The First FDA-Approved Antibody-Drug Conjugate
Combined therapy of dabrafenib and an anti-HER2 antibody–drug conjugate for advanced BRAF-mutant melanoma
Bone cement distribution may significantly affect the efficacy of percutaneous vertebroplasty in treating symptomatic Schmorl’s nodes
Molecular beam epitaxy growth and structural property of self-assembled InAs quantum dots on GaAs
Molecular beam epitaxy growth and structural property of self-assembled InAs quantum dots on GaAs
New conjugated polymers based on benzodifuranone and diketopyrrolopyrrole
Moist‐Defined Polymers with Tunable Multisteady Mechano‐Responsiveness Enabled by Imine‐Coordinated Boroxine
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
Pickering emulsions stabilized by polysaccharides-based micro/nanoparticeles
Causal impacts of smoking on pain conditions and the mediating pathways: a mendelian randomization study
Two-stage improved Grey Wolf optimization algorithm for feature selection on high-dimensional classification
First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors
The First FDA-Approved Antibody-Drug Conjugate
Combined therapy of dabrafenib and an anti-HER2 antibody–drug conjugate for advanced BRAF-mutant melanoma